Display Settings:

Format

Send to:

Choose Destination
    J Virol. 2010 Oct;84(20):10933-6. Epub 2010 Aug 11.

    The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3.

    Source

    Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT 59840, USA.

    Abstract

    APOBEC proteins have evolved as innate defenses against retroviral infections. Human immunodeficiency virus (HIV) encodes the Vif protein to evade human APOBEC3G; however, mouse retroviruses do not encode a Vif homologue, and it has not been understood how they evade mouse APOBEC3. We report here a murine leukemia virus (MuLV) that utilizes its glycosylated Gag protein (gGag) to evade APOBEC3. gGag is critical for infection of in vitro cell lines in the presence of APOBEC3. Furthermore, a gGag-deficient virus restricted for replication in wild-type mice replicates efficiently in APOBEC3 knockout mice, implying a novel role of gGag in circumventing the action of APOBEC3 in vivo.

    PMID:
    20702647
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2950561
    Free PMC Article

    Images from this publication.See all images (3) Free text

    FIG. 2.
    FIG. 1.
    FIG. 3.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk